Insider Selling: Sabra Healthcare REIT (NASDAQ:SBRA) Director Sells $209,800.00 in Stock

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Director Michael Foster sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total transaction of $209,800.00. Following the completion of the transaction, the director owned 72,834 shares in the company, valued at $1,528,057.32. This represents a 12.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Sabra Healthcare REIT Trading Down 0.6%

Shares of NASDAQ SBRA traded down $0.12 during mid-day trading on Friday, hitting $20.44. The stock had a trading volume of 2,327,185 shares, compared to its average volume of 2,722,799. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21. Sabra Healthcare REIT, Inc. has a 1 year low of $17.53 and a 1 year high of $22.77. The business has a 50 day moving average price of $19.88 and a two-hundred day moving average price of $20.04. The firm has a market cap of $5.35 billion, a P/E ratio of 73.00, a price-to-earnings-growth ratio of 1.79 and a beta of 0.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The firm had revenue of $249.57 million for the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The company’s quarterly revenue was up 31.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.38 earnings per share. On average, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be given a $0.30 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. Sabra Healthcare REIT’s payout ratio is presently 428.57%.

Institutional Trading of Sabra Healthcare REIT

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Lasalle Investment Management Securities LLC increased its position in Sabra Healthcare REIT by 8.2% during the 1st quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock valued at $73,547,000 after purchasing an additional 290,405 shares during the period. Dimensional Fund Advisors LP raised its holdings in Sabra Healthcare REIT by 7.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after purchasing an additional 269,793 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in Sabra Healthcare REIT by 70.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock worth $36,615,000 after purchasing an additional 765,527 shares in the last quarter. Rush Island Management LP purchased a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth about $30,735,000. Finally, Sound Income Strategies LLC lifted its position in shares of Sabra Healthcare REIT by 8.3% in the 3rd quarter. Sound Income Strategies LLC now owns 1,051,751 shares of the real estate investment trust’s stock worth $19,815,000 after purchasing an additional 80,453 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Citizens Jmp upped their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday, July 22nd. Huntington assumed coverage on shares of Sabra Healthcare REIT in a report on Monday, November 2nd. They set a “strong-buy” rating for the company. Weiss Ratings raised Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, November 3rd. Raymond James Financial upgraded Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Finally, Mizuho set a $21.00 price target on Sabra Healthcare REIT in a report on Monday, August 31st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $21.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.